Chronic Kidney Disease Stage 3 Clinical Trial
Official title:
Empowering Veterans to Communicate With Healthcare Providers to Improve CKD Care
Verified date | March 2022 |
Source | Northwestern University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The goal of this VA Innovation Seed project is to test the best approach for the delivery, feasibility, and usability of a patient-centered CKD-QPS to facilitate better Veteran understanding and engagement in their CKD-care in nephrology clinics at two geographically distinct VA hospitals (Chicago and Dallas) through on-going user feedback in real time.
Status | Terminated |
Enrollment | 8 |
Est. completion date | September 30, 2018 |
Est. primary completion date | September 30, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: 1. Adult (age 18+) English-speaking CKD patients stage 3 (eGFR = 30-70 mL/min) who are scheduled for a clinic visit will be eligible for participation. 1. Up to 60 will receive the QPS and all data collection activities 2. Up to 10 will be audio recorded only 2. Nephrologists (or Nurse Practitioners or Physician Assistants) seeing CKD patients in routine clinic visits will be eligible for participation at Hines, VA. Exclusion Criteria: 1. CKD patients who are non-English speaking, blind, hard of hearing or deaf, unable to read, and/or who are cognitively impaired will not be eligible for participation. |
Country | Name | City | State |
---|---|---|---|
United States | Jesse Brown Veterans Affairs Medical Center | Chicago | Illinois |
United States | Edward Hines, Jr. VA Hospital | Maywood | Illinois |
Lead Sponsor | Collaborator |
---|---|
Northwestern University | Edward Hines Jr. VA Hospital |
United States,
Lederer S, Fischer MJ, Gordon HS, Wadhwa A, Popli S, Gordon EJ. A question prompt sheet for adult patients with chronic kidney disease. BMC Nephrol. 2016 Oct 19;17(1):155. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Perceived efficacy in patient-physician interaction (PEPPI) | This measure, the full name of which is provided above, assesses patients' perceived self-efficacy or confidence in interacting with physicians. It includes 5 items, each of which is anchored by 1 (not at all confident) and 5 (very confident). Scores range from 5 to 25, which higher scores indicating greater confidence. | up to 2 days | |
Secondary | # Question Prompt Sheet (QPS) Questions Asked | Number of questions from the QPS that were asked during the clinic encounter. | 1 day | |
Secondary | Short-form patient satisfaction questionnaire (PSQ-18) | This measure assesses patients' perceptions of satisfaction in interacting with healthcare providers.
It includes 18 items, each of which is anchored by 1 (strongly agree) and 5 (strongly disagree). Scores range from 18 to 90, which lower scores indicating greater satisfaction with medical care. |
up to 2 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT05169411 -
Preserving Kidney Function in Children With Chronic Kidney Disease
|
N/A | |
Recruiting |
NCT03311321 -
Vitamin K to Slow Progression of Cardiovascular Disease Risk in Hemodialysis Patients
|
N/A | |
Active, not recruiting |
NCT05198284 -
Prospective Decision Impact Clinical Utility Trial of KidneyIntelX
|
||
Recruiting |
NCT05797506 -
Safety, Feasibility and Efficacy of Sulforaphane (Avmacol Extra Strength) in Chronic Kidney Disease
|
Phase 2 | |
Recruiting |
NCT01709994 -
Primary Cardiovascular Risk Prevention With Aspirin in Chronic Kidney Disease Patients
|
Phase 3 | |
Active, not recruiting |
NCT05225454 -
The Life Style Patterns and the Development Trend of Chronic Diseases in Healthy and Sub-healthy Groups Were Analyzed by Using Data-mining Techniques
|
||
Completed |
NCT01748396 -
Effect of Phosphate Binders on FGF-23 With Concurrent Calcitriol
|
Phase 4 | |
Completed |
NCT04012957 -
Desidustat in the Treatment of Anemia in CKD
|
Phase 3 | |
Completed |
NCT03242252 -
Safety and Efficacy Study of Sotagliflozin on Glucose Control in Participants With Type 2 Diabetes, Moderate Impairment of Kidney Function, and Inadequate Blood Sugar Control
|
Phase 3 | |
Recruiting |
NCT01509716 -
Assessing Perceived Versus Actual Knowledge and Quality of Life in Pre-Dialysis Chronic Kidney Disease (CKD) Patients
|
N/A |